4th Annual Vaccine Renaissance Conference

The nation’s top brass in the vaccine research and development field descended on Providence this October for The Institute for Immunology and Informatics 4th Annual Vaccine Renaissance Conference.

The conference served as an interactive program for the exchange of ideas among experts in vaccine research, vaccine delivery, clinical trials and basic immunology.

This year’s conference provided a great opportunity to learn about vaccines from the top researchers in the world. Among the guest speakers were Dr. Niranjan Sardesai of Inovio Pharmaceuticals. Dr. Sardesai presented a clinical trial update on the therapeutic HPV vaccine. Dr. Vincent Tuohy of the Lerner College of Medicine at the Cleveland Clinic highlighted his findings on a prophylactic breast cancer vaccination. Dr. Katharine Kripke of the National Institutes of Health provided an update on the current status of HIV vaccine research.

Joining Dr. Kripke from the NIH was renowned immunologist Dr. Polly Matzinger. Dr. Matzinger’s presentation focused on balancing tolerance and intolerance in vaccine design. A reception and award ceremony named in Dr. Matzinger’s honor followed her presentation. Dr. Richard Glass of Bryant University and University of Rhode Island biotech graduate student Roxanne LaCroix were presented the Smart Vaccines for Entrepreneurs award.

Click here to read about Dr. Glass and Roxanne LaCroix in the Providence Business News!

Vaccine Renaissance Conference Presentations

Michael BrehmHumanized Mouse Models for Vaccine Development

R. Mark BullerSmallpox and Monkey Pox: Testing and Development of Orthopox Vaccines

Manon CoxPreparing for the Next Pandemic: Rapid “Novel” Flu Vaccine Product (Getting the First Recombinant Influenza Vaccine Approved)

Alan CrossAn Anti-Sepsis Vaccine? LPS Vaccine Development Update

Les DupuyThe Development of Multi-Epitope DNA Vaccines for Biodefense Applications

Steve Gregory, Phyllis Losikoff, Loren FastImmunome-Derived, Multi Epitope, Dendritic Cell Pulsed HCV Vaccine

Daniel HoftRomana’s Sign of the Times: Molecular

Bolyn HubbyNanoparticle Vaccine Carriers and Adjuvants

William Martin, Matt Ardito, Gary KurczyVaccine Design for Advanced Users: Computer Training: T Cell Epitope Prediction

Katharine KripkeGood News and Promise for the Future: The Status of HIV Vaccine Research

Tom Mather, Wendy Coy – Salivome-Derived Epitope-Driven Approach to Development of a Tick Vaccine

Ted RossVLP’s for Better Vaccine Delivery

Niranjan SardesaiTherapeutic HPV Vaccine – Clinical Trial Update

Liisa SelinNew Concepts – Heterologous Immunity and the Importance of Rational Vaccine Design

Devon ShedlockEffective T Cell Responses to DNA Vaccines


  • April 15, 2016

    ISV & Vaccine Renaissance Conference – CALL FOR ABSTRACTS!

    The 2016 ISV Annual Congress in collaboration with Vaccine Renaissance X and DNA Vaccine will be held in Boston, Massachusetts, United States on Oct. 2-4, 2016.    Registration abstract is opening soon! The planning committee encourages you to submit an abstract for consideration! Abstract Submission Deadline: June 24th Abstract Decision Deadline: July 15th   http://www.isvcongress.org/
  • March 11, 2016

    10th Annual Vaccine Renaissance Save the Date Postcard

    CLICK HERE to see the save the date postcard for 2016 ISV Conference
  • February 19, 2016

    iCubed Team Members Making Moves

    This past week at iCubed, Dr. Barbara Lohman Payne received a new title of Associate Research Professor. Barbara joined iCubed and URI as a Research Assistant Professor in 2013, with the Laboratory of Viral Immunity and Pathogenesis. Dr. Lohman-Payne’s area of research is viral immunopathology, with special interest in the impact of HIV exposure in ...